Company / Capital Expenditures
EyePoint, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$3.3M
FY2025
5-year range
$362.0K / $3.5M
FY2021-FY2025
Trend
-5.8%
vs FY2024
Sector context
#137 of 151
Health Care
What the data says
Among 151 Health Care companies, EyePoint, Inc. is in the bottom 9% for capital expenditures. Capital Expenditures has fluctuated over the past 10 years, ranging from $108,000 in FY2018 to $3M in FY2024.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of +72.8%.
Improved from $2M to $3M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +15.1%
- 5-Year CAGR
- +72.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 151This company $3.3M Sector average $271.7M
▼
-98.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +72.8%, indicating consistent growth.
- In FY2025, capital expenditures decreased 5.8% year-over-year.
- Ranks #137 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.3M | -5.8% |
| FY2024 | $3.5M | +62.0% |
| FY2023 | $2.1M | +0.0% |
| FY2022 | $2.1M | +493.9% |
| FY2021 | $362.0K | +70.0% |
| FY2020 | $213.0K | +44.9% |
| FY2019 | $147.0K | +36.1% |
| FY2018 | $108.0K | -26.5% |
| FY2017 | $147.0K | +30.1% |
| FY2016 | $113.0K | +66.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026